We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 315

Second Circuit’s Mandate Rule Limits New Causation Theories on Remand
  • McDermott Will & Emery
  • USA
  • July 18 2018

On remand, indirect purchasers of the drug ACTOS sought to amend their antitrust complaint to modify their causal theory of harm. The district court


How Many Infringers Does It Take to “Administer” a Medication?
  • McDermott Will & Emery
  • USA
  • July 18 2018

Addressing the issue of whether defendant's abbreviated new drug application (ANDA) formulation would infringe plaintiff's method patents under a


Teva’s Skinny Label Found Not to Induce Infringement by Off-Label Use
  • McDermott Will & Emery
  • USA
  • July 18 2018

The US District Court for the District of Delaware granted in part Teva Pharmaceuticals' renewed motion for judgment as a matter of law (JMOL


Stability of Ready-to-Use Dexmedetomidine Not Inherent
  • McDermott Will & Emery
  • USA
  • July 18 2018

After a bench trial, the US District Court for the District of Delaware found several Hospira patents covering a diluted, "ready-to-use" composition


Lower Court’s Factual Finding Given Deference in “Close Case”
  • McDermott Will & Emery
  • USA
  • June 28 2018

The US Court of Appeals for the Federal Circuit affirmed the district court's finding that a skilled artisan would have had no reasonable expectation


Recycle, Recycle, Recycle: Key Considerations for Research, Medical Education, and Other Secondary Uses of Data
  • McDermott Will & Emery
  • USA
  • June 6 2018

The digitization of health care and the proliferation of electronic medical records is happening rapidly, generating large quantities of data with


The latest: Health Care Antitrust Enforcement Remains a Top Priority for New FTC Commissioners
  • McDermott Will & Emery
  • USA
  • May 4 2018

On April 27, 2018, the United States Senate confirmed President Trump’s five nominees for Commissioners of the Federal Trade Commission (FTC). Three


FDA Extends Compliance Date for Updated Nutrition Facts Label
  • McDermott Will & Emery
  • USA
  • May 4 2018

The Food and Drug Administration (FDA) is extending the compliance dates for updating the familiar Nutrition Facts labels, from July 26, 2018 to


Deference, Discovery and District Court Findings
  • McDermott Will & Emery
  • USA
  • March 28 2018

Giving deference on discovery issues and non-infringement findings, the US Court of Appeals for the Federal Circuit affirmed a non-infringement


New DOJ Task Force to Take on Opioid Crisis Using the FCA and Other Enforcement Tools
  • McDermott Will & Emery
  • USA
  • March 2 2018

Earlier this week, the US Department of Justice (DOJ) launched a new front in its effort to combat the opioid crisis and explicitly stated that it